Background In 2018, two patent applications (EP3564144 and EP3563896) were filed by the same applicant, Dr Thaler, and initially failed to provide information about the inventor. After notification from the EPO regarding the missing inventor details, the applicant...
Background In our previous article, we discussed the expected referral to the Enlarged Board of Appeal in case T 116/18, wherein the Board of Appeal decided greater clarity was required concerning the use of post-published data when considering inventive step. The...
Background Dr Thaler filed two UK patent applications and subsequently filed Form 7’s stating that the inventor for both applications was the AI system “DABUS”. Dr Thaler also indicated on the Form 7’s that he had acquired the right to be...
Background In 2008, the State Council of China issued its “Outline of the National Intellectual Property Strategy”, which set a target of increasing the administration and use of IP rights in China by 2020. Last year, the State Council Information Office...
Belcher’s patent related to a high-pH formulation of L-epinephrine (L-adrenaline) and was granted with a claim to a formulation of pH 2.8-3.3. The formulation of L-epinephrine was also the subject of a new drug application before the FDA. Hospira, who were...
Recent Comments